Even though Punxsutawney Phil has predicted six more weeks of winter weather, ballparks in Florida and Arizona are prepared to provide a compelling counterargument. Spring (training) is just around ...

Enlicitide decanoate, an oral proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor, was shown to reduce low-density lipoprotein (LDL) cholesterol levels in a phase 2 trial; longer-term data ...

It's Groundhog Day 2026, and Punxsutawney Phil predicted we will see six more weeks of winter. While many booed and scowled at the idea of more cold, the woodchuck may not be so far off. The first day ...

MLB players will begin defrosting in February for the start of spring training ahead of the 2026 regular season, which begins at the end of March. The players from all 30 teams will either travel down ...

Chances are, your cholesterol isn’t something you think too much about. When it comes to your health, your thoughts may already be preoccupied with figuring out more ways to get protein, how to get ...

Artificial intelligence and related technologies are evolving rapidly, but until recently, Java developers had few options for integrating AI capabilities directly into Spring-based applications.

NEW YORK - Health experts say drinking orange juice might be a simple way to help lower “bad” cholesterol, also known as LDL. Some studies show that natural ingredients in oranges, as well as special ...

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death in the United States and globally, accounting for approximately 25% of all deaths in the U.S. alone. Despite advances ...

What Is Leqvio, and Why Does It Matter? Leqvio (inclisiran) is a prescription injection that helps lower levels of low-density lipoprotein cholesterol (LDL), often called “bad” cholesterol, which is a ...

Model Context Protocol, or MCP, is arguably the most powerful innovation in AI integration to date, but sadly, its purpose and potential are largely misunderstood. So what's the best way to really ...

Clare Collins AO is a Laureate Professor in Nutrition and Dietetics at the University of Newcastle, NSW and a Hunter Medical Research Institute (HMRI) affiliated researcher. She is a National Health ...

A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or “bad” cholestero l, when statins aren’t helping enough. In the Phase 3 ...